Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Naureen Mushtaq is active.

Publication


Featured researches published by Naureen Mushtaq.


Journal of Pediatric Hematology Oncology | 2015

Peripherally Inserted Central Venous Catheters in Pediatric Hematology/Oncology Patients in Tertiary Care Setting: A Developing Country Experience.

Zehra Fadoo; Muhammad Imran Nisar; Raza Iftikhar; Sajida Ali; Naureen Mushtaq; Raza Sayani

Purpose: Peripherally inserted central venous catheters (PICC) have been successfully used to provide central access for chemotherapy and frequent transfusions. The purpose of this study was to assess the feasibility of PICCs and determine PICC-related complications in pediatric hematology/oncology patients in a resource-poor setting. Methods: All pediatric patients (age below 16 y) with hematologic and malignant disorders who underwent PICC line insertion at Aga Khan University Hospital from January 2008 to June 2010 were enrolled in the study. Demographic features, primary diagnosis, catheter days, complications, and reasons for removal of device were recorded. Results: Total of 36 PICC lines were inserted in 32 pediatric patients. Complication rate of 5.29/1000 catheter days was recorded. Our study showed comparable complication profile such as infection rate, occlusion, breakage, and dislodgement. The median catheter life was found to be 69 days. Conclusions: We conclude that PICC lines are feasible in a resource-poor setting and recommend its use for chemotherapy administration and prolonged venous access.


Journal of Infection in Developing Countries | 2014

Risk factors for complicated varicella infection in pediatric oncology patients at a tertiary health care facility in Pakistan.

Muhammad Matloob Alam; Farah Naz Qamar; Zalan Wahid Khan; Vikram Kumar; Naureen Mushtaq; Zehra Fadoo

INTRODUCTION Varicella zoster infection (VZI) is well recognized as a potential cause of morbidity and mortality in immunocompromised pediatric oncology patients (POP). The purpose of this study was to describe the clinical profile and risk factors for complications and outcomes of VZI in POP treated with acyclovir. METHODOLOGY Medical records of all POP with a discharge diagnosis of VZI over a period of seven years (2005-2011) were reviewed. The demographic features, underlying malignancy, risk factors for VZI, complications, and outcomes were recorded. RESULTS Thirty-six POP with VZI were identified. Leukemia was the most common underlying malignancy (n = 20, 58.8%), followed by lymphoma (n = 7, 20.6%) and solid organ tumors (n = 7, 20.6%). Most of the cases (41%) were observed in children under five. All patients were treated with acyclovir. Varicella-related complications developed in 10 (29%) patients. The most frequent complication was bloodstream infection (n = 3, 8.8%), followed by pneumonia (n = 2, 5.9%), skin infection (n = 2, 5.9%), hepatitis, renal failure, and encephalitis. Independent risk factors associated with complications were age < five years, weight for age < fifth percentile, delay in seeking care (> seven days after onset of symptoms) and severe neutropenia (ANC < 500/cm). One child died secondary to varicella encephalitis. CONCLUSION Our data suggests that young age, poor health-seeking behavior, severe neutropenia, and being underweight are the major risk factors for the development of varicella-related complications in POP in developing countries. These complications could be favorably modified through active immunization of immunocompetent children.


Pediatric Blood & Cancer | 2017

SIOP PODC Adapted treatment guidelines for low grade gliomas in low and middle income settings

Laila Hessissen; Jeannette Parkes; Nisreen Amayiri; Naureen Mushtaq; Nongnuch Sirachainan; Yavuz Anacak; Dipayan Mitra; Anthony A. Figaji; Antoinette Y. N. Schouten-van Meeteren; Michael Sullivan; Hester Burger; Alan Davidson; Eric Bouffet; Simon Bailey

Effective treatment of children with low grade glioma (LGG) requires a functioning multi‐disciplinary team with adequate neurosurgical, neuroradiological, pathological, radiotherapy and chemotherapy facilities and personnel. In addition, the treating centre should have the capacity to manage a variety of LGG and treatment‐associated complications. These requirements have made it difficult for many centers in low and middle‐income countries (LMIC) to offer effective treatment and follow up. This article provides management recommendations for children with LGG according to the level of facilities available.


Journal of Pakistan Medical Association | 2013

Childhood acute lymphoblastic leukaemia: experience from a single tertiary care facility of Pakistan.

Naureen Mushtaq; Zehra Fadoo; Ahmed Naqvi


Journal of Pakistan Medical Association | 2000

The effect of grandmultiparity on pregnancy related complications: the Aga Khan University experience.

Shama Munim; Mohammad H. Rahbar; M. Rizvi; Naureen Mushtaq


Journal of Pakistan Medical Association | 2012

Acute myeloid leukaemia in children: experience at a tertiary care facility of Pakistan

Zehra Fadoo; Naureen Mushtaq; Saima Alvi; Muhammad Asghar Ali


Jcpsp-journal of The College of Physicians and Surgeons Pakistan | 2012

Acute Lymphoblastic Leukemia in a Child with Fanconi's Anaemia

Naureen Mushtaq; Rabia Wali; Zehra Fadoo; Ali Faisal Saleem


Journal of Pakistan Medical Association | 2014

Ovarian haemorrhage: a rare presentation and diagnostic dilemma in factor XIII deficiency.

Alam Mm; Iftikhar Ar; Naureen Mushtaq; Zehra Fadoo


Journal of Pakistan Medical Association | 2014

A case of autoimmune haemolytic anaemia achieving complete response with rituximab.

Maha Dev; Naureen Mushtaq; Ali Faisal


Neuro-oncology | 2017

BIOL-02. INTRACRANIAL TUMORS IN CHILDREN: A 10 YEAR REVIEW FROM A SINGLE TERTIARY HEALTH CARE CENTRE

Quratulain Riaz; Ehsan Naeem; Zehra Fadoo; Maha Dev; Naureen Mushtaq

Collaboration


Dive into the Naureen Mushtaq's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nisreen Amayiri

King Hussein Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge